Loading...
Header Logo
Keywords
Last Name
Institution

JAVIER A ADACHI

TitleProfessor
InstitutionMD Anderson
DepartmentInfectious Diseases, Infection Control, and Employee Health
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Abu-Sbeih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi JA, Hachem RY, Altan M, Jenq RR, Wang Y. Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum. 2020 03; 63(3):381-388. PMID: 31842164.
      View in: PubMed
    2. Taremi M, Artau A, Foolad F, Berlin S, White C, Jiang Y, Raad I, Adachi J. Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2185-2191.e1. PMID: 30928660.
      View in: PubMed
    3. Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS. A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2019 01 07; 68(2):196-203. PMID: 29893798.
      View in: PubMed
    4. Alvarez RH, Bechara RI, Naughton MJ, Adachi JA, Reuben JM. Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer. Oncologist. 2018 06; 23(6):660-669. PMID: 29487226.
      View in: PubMed
    5. Munita JM, Aitken SL, Miller WR, Perez F, Rosa R, Shimose LA, Lichtenberger PN, Abbo LM, Jain R, Nigo M, Wanger A, Araos R, Tran TT, Adachi J, Rakita R, Shelburne S, Bonomo RA, Arias CA. Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa. Clin Infect Dis. 2017 07 01; 65(1):158-161. PMID: 28329350.
      View in: PubMed
    6. Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39. PMID: 28254252.
      View in: PubMed
    7. Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520. PMID: 27045126.
      View in: PubMed
    8. Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol. 2015 Feb; 64(Pt 2):191-4. PMID: 25627208.
      View in: PubMed
    9. Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S335-9. PMID: 25352627.
      View in: PubMed
    10. Esmaily-Fard A, Tverdek FP, Crowther DM, Ghantoji SS, Adachi JA, Chemaly RF. The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy. 2014 Nov; 34(11):1220-5. PMID: 25164587.
      View in: PubMed
    11. Munita JM, Mishra NN, Alvarez D, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Adachi JA, Bayer AS, Arias CA. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions. Clin Infect Dis. 2014 Nov 01; 59(9):1277-80. PMID: 25107294.
      View in: PubMed
    12. Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect. 2014 Oct; 20(10):O672-9. PMID: 24529214.
      View in: PubMed
    13. Rincón S, Reyes J, Carvajal LP, Rojas N, Cortés F, Panesso D, Guzmán M, Zurita J, Adachi JA, Murray BE, Nannini EC, Arias CA. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother. 2013 Dec; 68(12):2773-8. PMID: 23794599.
      View in: PubMed
    14. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36. PMID: 22707509.
      View in: PubMed
    15. Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J. 2012 Apr; 31(4):373-8. PMID: 22228234.
      View in: PubMed
    16. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale PS, Davila M, Raad II. Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis. 2012 Mar 01; 54(5):740-2. PMID: 22322272.
      View in: PubMed
    17. Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33. PMID: 22359314.
      View in: PubMed
    18. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-ß-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother. 2012 May; 56(5):2364-70. PMID: 22354301.
      View in: PubMed
    19. Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, Vigil K, Adachi JA, Khoury AM, Tarrand J, Hosing C, Champlin R. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012 Mar 22; 119(12):2738-45; quiz 2969. PMID: 22246027.
      View in: PubMed
    20. Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect. 2011 Nov; 63(5):394-7. PMID: 21839773.
      View in: PubMed
    21. Chemaly RF, Rathod DB, Sikka MK, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Trenholme G, Raad I. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: a multi-state report. Am J Infect Control. 2011 Aug; 39(6):521-4. PMID: 21492963.
      View in: PubMed
    22. Vigil KJ, Adachi JA, Chemaly RF. Viral pneumonias in immunocompromised adult hosts. J Intensive Care Med. 2010 Nov-Dec; 25(6):307-26. PMID: 20837633.
      View in: PubMed
    23. Parikh SA, Bhusal Y, Faderl SH, Wierda WG, O'Brien S, Kantarjian H, Adachi JA, Burger JA. The great imitator: systemic nocardiosis mimicking Richter's transformation in relapsed chronic lymphocytic leukemia. J Clin Oncol. 2010 Dec 10; 28(35):e732-4. PMID: 20823404.
      View in: PubMed
    24. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6. PMID: 20452752.
      View in: PubMed
    25. Panesso D, Reyes J, Rincón S, Díaz L, Galloway-Peña J, Zurita J, Carrillo C, Merentes A, Guzmán M, Adachi JA, Murray BE, Arias CA. Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol. 2010 May; 48(5):1562-9. PMID: 20220167.
      View in: PubMed
    26. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80. PMID: 20038242.
      View in: PubMed
    27. Reyes J, Rincón S, Díaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Rizzi A, Guzmán M, Adachi J, Chowdhury S, Murray BE, Arias CA. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis. 2009 Dec 15; 49(12):1861-7. PMID: 19911971.
      View in: PubMed
    28. Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-20. PMID: 19593226.
      View in: PubMed
    29. Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5. PMID: 19487050.
      View in: PubMed
    30. Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. Am J Trop Med Hyg. 2009 Apr; 80(4):606-8. PMID: 19346385.
      View in: PubMed
    31. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control. 2009 Aug; 37(6):442-6. PMID: 19118923.
      View in: PubMed
    32. Vigil KJ, Mulanovich VE, Chemaly RF, Tarrand J, Raad II, Adachi JA. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med. 2009 Mar; 265(3):397-400. PMID: 19019183.
      View in: PubMed
    33. Georgescu G, Isola IM, Youssef S, Adachi J, Rolston K. Disseminated salmonellosis in a patient treated with temozolomide. J Infect. 2008 Nov; 57(5):414-5. PMID: 18715650.
      View in: PubMed
    34. Youssef S, Hachem R, Chemaly RF, Adachi J, Ying J, Rolston K, Raad I. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother. 2008 Feb; 61(2):421-4. PMID: 18174198.
      View in: PubMed
    35. Ghanem G, Adachi J, Han XY, Raad I. Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol. 2007 May; 28(5):599-601. PMID: 17464923.
      View in: PubMed
    36. Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang DB, Dupont MW, Adachi JA, De La Cabada FJ, Taylor DN, Jaini S, Martinez Sandoval F. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):451-6. PMID: 17382603.
      View in: PubMed
    37. Qazilbash MH, Ueno NT, Hosing C, De Lima M, Cortes J, Massaro A, Rivera Z, Deavers M, Adachi JA, Champlin RE. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant. 2006 Sep; 38(5):393-4. PMID: 16845427.
      View in: PubMed
    38. Adachi JA, DuPont HL. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis. 2006 Feb 15; 42(4):541-7. PMID: 16421799.
      View in: PubMed
    39. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79. PMID: 16143517.
      View in: PubMed
    40. Lee SA, Raad II, Adachi JA, Han XY. Catheter-related bloodstream infection caused by Mycobacterium brumae. J Clin Microbiol. 2004 Nov; 42(11):5429-31. PMID: 15528764.
      View in: PubMed
    41. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, DuPont HL. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis. 2003 Nov 01; 37(9):1165-71. PMID: 14557959.
      View in: PubMed
    42. Estrada-García MT, Jiang ZD, Adachi J, Mathewson JJ, DuPont HL. Intestinal immunoglobulin a response to naturally acquired enterotoxigenic Escherichia coli in US travelers to an endemic area of Mexico. J Travel Med. 2002 Sep-Oct; 9(5):247-50. PMID: 12962598.
      View in: PubMed
    43. Adachi JA, Mathewson JJ, Jiang ZD, Ericsson CD, DuPont HL. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med. 2002 Jun 18; 136(12):884-7. PMID: 12069562.
      View in: PubMed
    44. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Pallegar SR, DuPont HL. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis. 2002 Jun 01; 185(11):1681-3. PMID: 12023779.
      View in: PubMed
    45. DuPont HL, Jiang ZD, Ericsson CD, Adachi JA, Mathewson JJ, DuPont MW, Palazzini E, Riopel LM, Ashley D, Martinez-Sandoval F. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001 Dec 01; 33(11):1807-15. PMID: 11692292.
      View in: PubMed
    46. Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, Steffen R, Ericsson CD, DuPont HL. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis. 2001 Jun 15; 32(12):1706-9. PMID: 11360211.
      View in: PubMed
    47. Gomi H, Jiang ZD, Adachi JA, Ashley D, Lowe B, Verenkar MP, Steffen R, DuPont HL. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother. 2001 Jan; 45(1):212-6. PMID: 11120968.
      View in: PubMed
    48. Huang DB, Jiang ZD, Ericsson CD, Adachi J, Dupont HL. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico. Scand J Infect Dis. 2001; 33(11):812-4. PMID: 11760159.
      View in: PubMed
    49. Adachi JA, Jiang Z, Cox M, Wood L, DuPont HL, Mathewson JJ. Serum antibody response induced in mice after oral administration of three different antigens of enterotoxigenic Escherichia coli in enteric coated microparticles. J Travel Med. 2000 Nov-Dec; 7(6):304-8. PMID: 11179951.
      View in: PubMed
    50. Adachi JA, Ostrosky-Zeichner L, DuPont HL, Ericsson CD. Empirical antimicrobial therapy for traveler's diarrhea. Clin Infect Dis. 2000 Oct; 31(4):1079-83. PMID: 11049792.
      View in: PubMed
    51. Bouckenooghe AR, Dupont HL, Jiang ZD, Adachi J, Mathewson JJ, Verenkar MP, Rodrigues S, Steffen R. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg. 2000 Jun; 62(6):711-3. PMID: 11304060.
      View in: PubMed
    52. Sutjita M, Bouckenooghe AR, Adachi JA, Jiang ZD, Mathewson JJ, Ericsson CD, DuPont HL. Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea. Clin Diagn Lab Immunol. 2000 May; 7(3):501-3. PMID: 10799468.
      View in: PubMed
    53. Adachi JA, D'Alessio FR, Ericsson CD. Reactive arthritis associated with typhoid vaccination in travelers: report of two cases with negative HLA-B27. J Travel Med. 2000 Jan; 7(1):35-6. PMID: 10689239.
      View in: PubMed
    54. Caeiro JP, Estrada-Garcia MT, Jiang ZD, Mathewson JJ, Adachi JA, Steffen R, DuPont HL. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique. J Infect Dis. 1999 Dec; 180(6):2053-5. PMID: 10558969.
      View in: PubMed
    55. De Las Casas C, Adachi J, Dupont H. Review article: travellers' diarrhoea. Aliment Pharmacol Ther. 1999 Nov; 13(11):1373-8. PMID: 10571591.
      View in: PubMed
    56. Adachi JA, Barriga J, Ericsson CD. Bacterial gut infections. Curr Opin Infect Dis. 1999 Oct; 12(5):459-66. PMID: 17035812.
      View in: PubMed
    57. Glandt M, Adachi JA, Mathewson JJ, Jiang ZD, DiCesare D, Ashley D, Ericsson CD, DuPont HL. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis. 1999 Aug; 29(2):335-8. PMID: 10476738.
      View in: PubMed
    58. Adachi JA, Grimm EM, Johnson P, Uthman M, Kaplan B, Rakita RM. Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature. Transplantation. 1997 Oct 27; 64(8):1139-42. PMID: 9355830.
      View in: PubMed
    59. World alliance against antibiotic resistance. Medicina Intensiva. 39:34-39.
    60. Erratum. Clinical Infectious Diseases. 42:896.
    61. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. Journal of Medical Microbiology. 64:191-194.
    62. SENSIBILIDAD ANTIMICROBIANA IN VITRO DE CEPAS DE BRUCELLA MELITENSIS AISLADAS EN UNA AREA ENDEMICA (LIMA, PERU). Revista Espanola de Quimioterapia. 6:309-313.
    63. Gastrointestinal mucormycosis. Gastroenterology and Hepatology. 5:661-662.
    64. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated with Daptomycin. Clinical Infectious Diseases. 62:1514-1520.
    65. Serum antibody response induced in mice after oral administration of B subunit of cholera toxin and formalin-killed enterotoxigenic E. coli in enteric coated microparticles. Clinical Infectious Diseases. 25:467.
    ADACHI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description